Filtered Listing Testing
Este recurso analiza las condiciones médicas que pueden afectar la conducción, consejos de conducción segura y estrategias, un auto-examen para los conductores, evaluación y discusión de prácticas inseguras de conducción y el mantenimiento de la independencia una vez que se tomó la decisión de dejar de conducir.
Two BrightFocus grantees are honored by receiving the 2015 MetLife Foundation Awards in Medical Research, which work to stimulate novel investigations in the field of Alzheimer’s disease.
Scott Rodgville, a prominent Baltimore area CPA, has been elected chair of the Board of Directors of the BrightFocus Foundation, a Maryland non-profit supporting innovative research worldwide on Alzheimer’s, macular degeneration, and glaucoma.
Download the summer 2015 issue of our glaucoma newsletter to learn about how a healthy diet leads to healthy eyes, how to make your computer vision-friendly, and much more.
BrightFocus Foundation seeks to save sight and mind by funding innovative research worldwide and by promoting better health through education.
In an online report published April 2, 2014, BrightFocus researchers Matthew Campbell, PhD, Sarah Doyle, PhD, and Peter Humphries, PhD, and their teams, have reported from studies in mice that the inflammatory cytokine interleukin-18 (IL-18) can prevent choroidal neovascularization (CNV) formation—the fragile, leaky blood vessels forming on the retina that are the hallmark of wet AMD—and is not toxic to the retinal pigment epithelium.
Recent BrightFocus grantees, Vinit B. Mahajan, MD, PhD, and co-investigator Jessica M. Skeie, PhD, of the University of Iowa mapped the location and quantities of some 4,403 different proteins expressed in the retinal pigment epithelium (RPE) and choroid of the healthy human eye. This molecular map now provides clues as to why certain areas of the choroid are more sensitive to certain diseases, as well as where to target therapies and why.